Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR receptor occupation optimization in NET-related symptoms
2014-003856-30Phase 4Terminated
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Oct 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of octreotide in apudoma (NET), sponsored by Cliniques universitaires Saint-Luc. Primary endpoints: Change in incidence of diarrhea and flushing from baseline and Number of symptoms in correlation with serum octreotide level. Started Oct 2015; status: terminated.
02
Drugs
octreotide
03
Conditions
apudoma (NET)
Beyond the preview
Go deeper on 2014-003856-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003856-30.